Daiichi Sankyo Co., Ltd. (DSKYF)
18.24
+0.01
(+0.04%)
USD |
OTCM |
Aug 25, 16:00
Daiichi Sankyo Enterprise Value : 32.37B for Aug. 25, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| August 25, 2026 | 32.37B |
| August 24, 2026 | 32.35B |
| August 21, 2026 | 31.92B |
| August 20, 2026 | 31.92B |
| August 19, 2026 | 31.03B |
| August 18, 2026 | 30.69B |
| August 17, 2026 | 30.69B |
| August 14, 2026 | 29.03B |
| August 13, 2026 | 29.03B |
| August 12, 2026 | 29.03B |
| August 11, 2026 | 29.03B |
| August 10, 2026 | 30.83B |
| August 07, 2026 | 30.83B |
| August 06, 2026 | 31.10B |
| August 05, 2026 | 28.23B |
| August 04, 2026 | 28.23B |
| August 03, 2026 | 30.57B |
| July 31, 2026 | 28.16B |
| July 30, 2026 | 29.37B |
| July 29, 2026 | 30.16B |
| July 28, 2026 | 30.69B |
| July 27, 2026 | 32.03B |
| July 24, 2026 | 28.19B |
| July 23, 2026 | 31.04B |
| July 22, 2026 | 30.16B |
| Date | Value |
|---|---|
| July 21, 2026 | 30.18B |
| July 20, 2026 | 30.85B |
| July 17, 2026 | 27.94B |
| July 16, 2026 | 28.28B |
| July 15, 2026 | 29.19B |
| July 14, 2026 | 30.42B |
| July 13, 2026 | 30.42B |
| July 10, 2026 | 31.23B |
| July 09, 2026 | 29.57B |
| July 08, 2026 | 29.57B |
| July 07, 2026 | 29.56B |
| July 06, 2026 | 28.01B |
| July 02, 2026 | 27.80B |
| July 01, 2026 | 27.73B |
| June 30, 2026 | 29.99B |
| June 29, 2026 | 30.19B |
| June 26, 2026 | 27.94B |
| June 25, 2026 | 26.23B |
| June 24, 2026 | 26.23B |
| June 23, 2026 | 27.62B |
| June 22, 2026 | 28.21B |
| June 18, 2026 | 29.58B |
| June 17, 2026 | 28.77B |
| June 16, 2026 | 26.76B |
| June 15, 2026 | 28.88B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Shionogi & Co., Ltd. | 17.95B |
| Astellas Pharma, Inc. | 29.32B |
| AstraZeneca PLC | 552.52B |
| Takeda Pharmaceutical Co., Ltd. | 85.56B |
| Eisai Co., Ltd. | 8.547B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 430.72M |
| Revenue (Quarterly) | 3.607B |
| Total Expenses (Quarterly) | 3.176B |
| EPS Diluted (Quarterly) | 0.2366 |
| Gross Profit Margin (Quarterly) | 78.37% |
| Profit Margin (Quarterly) | 11.94% |
| Earnings Yield | 4.68% |
| Operating Earnings Yield | 3.79% |
| Normalized Earnings Yield | 4.677 |